Astrana Health (ASTH) closed at $34.50 on November 6, 2026, down 11.6% from the previous close, on volume of 1,055,730 shares (30-day average 305,578).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Astrana Health Earnings Call Highlights Growth and Deleveraging
TipRanks (Fri, 6-Nov 7:21 PM ET)
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH) and RegenXBio (RGNX)
TipRanks (Fri, 6-Nov 4:20 AM ET)
Astrana Health Non-GAAP EPS of $0.71 misses by $0.17, revenue of $1.02B in-line
Seeking Alpha News (Thu, 5-Nov 5:51 PM ET)
Astrana Health Reports Strong Third-Quarter Revenue and Earnings Growth
TipRanks (Thu, 5-Nov 4:48 PM ET)
Astrana Health, Inc. Reports Third Quarter 2026 Results
PRNewswire (Thu, 5-Nov 4:05 PM ET)
PRNewswire (Thu, 15-Oct 10:02 AM ET)
Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership
Business Wire (Sat, 10-Oct 3:05 PM ET)
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
PRNewswire (Fri, 9-Oct 4:06 PM ET)
Globe Newswire (Tue, 29-Sep 4:59 PM ET)
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
Business Wire (Tue, 29-Sep 8:06 AM ET)
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Astrana Health trades on the NASDAQ stock market under the symbol ASTH.
As of November 6, 2026, ASTH stock price declined to $34.50 with 1,055,730 million shares trading.
ASTH has a beta of 1.30, meaning it tends to be more sensitive to market movements. ASTH has a correlation of 0.07 to the broad based SPY ETF.
ASTH has a market cap of $1.71 billion. This is considered a Small Cap stock.
Last quarter Astrana Health reported $1 billion in Revenue and $.26 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.53.
The top ETF exchange traded funds that ASTH belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.
ASTH has underperformed the market in the last year with a price return of +3.4% while the SPY ETF gained +10.8%. However, in the short term, ASTH had mixed performance relative to the market. It has outperformed in the last 3 months, returning +1.1% vs -4.1% return in SPY. But in the last 2 weeks, ASTH shares have been beat by the market, returning -7.9% compared to an SPY return of -3.2%.
ASTH support price is $37.79 and resistance is $40.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASTH shares will trade within this expected range on the day.
